[Inhibitory effect of clarithromycin on NF-kappaB activation].
Ichiyama
T
T
Nishikawa
K
K
Yoshitomi
T
T
Hasegawa
T
T
Matsubara
T
T
Furukawa
S
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004768:Enterotoxins / Q000037:antagonists & inhibitors; D006801:Humans; D019169:Jurkat Cells / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000900:Anti-Bacterial Agents; D004768:Enterotoxins; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; C026066:enterotoxin A, Staphylococcal; D017291:Clarithromycin